Clinical efficacy of the antiviral drug "Panavir" in a complex treatment of chronic recurrent herpetic stomatitis
The results of evaluating the effectiveness of Panavir in the complex therapy of chronic recurrent herpetic stomatitis presented. Two randomized groups were formed (39 patients - the main group, 37 - the control group) from the number of patients who applied to the Republican Dental Clinic. Evaluation of the effect carried out at the end of the course of treatment with Panavir (on the 25th day of treatment). The results of the study showed that the inclusion of Panavir in the complex treatment regimen has a more pronounced clinical effect, which is manifested by a decrease in the duration of clinical manifestations, a decrease in the frequency of exacerbations, an extension of the remission period and a significant increase in the concentration of secretory immunoglobulin A (SIgA) in saliva, indicating that more pronounced effect on local immunity.